Related Experiment Video
Updated: May 19, 2026

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis
Published on: August 7, 2018
Regulatory complexity and therapeutic targeting of the necroptosis network
Lipan Niu1,2, Fengxia Liu1,2, Yuxin Zhao1,2
1School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, Xinjiang, China.
Abstract:
Necroptosis, a regulated form of necrotic cell death governed by the RIPK1-RIPK3-MLKL axis, is critically involved in host defense, inflammatory responses, and the pathogenesis of diverse diseases. Given the expanding complexity of its signaling networks and their context-dependent outcomes, a synthesized overview is essential. This review aims to: (1) delineate both canonical and non-canonical pathways of necroptosis induction; (2) elucidate the multifaceted regulation of its core executors (RIPK1, RIPK3, MLKL) by post-translational modifications and epigenetic mechanisms; and (3) analyze the intricate crosstalk between necroptosis and other cellular processes, including apoptosis, autophagy, and metabolic pathways. The subsequent analysis will evaluate how this sophisticated regulatory architecture poses challenges while unveiling novel therapeutic vulnerabilities. Finally, emerging translational strategies that target necroptosis in inflammatory, neurodegenerative, and ischemic conditions are discussed, and propose future directions to bridge mechanistic discoveries to clinical applications. Notably, beyond its pathogenic roles, necroptosis also functions as an essential host defense mechanism against viral infection and represents a promising therapeutic strategy for eliminating apoptosis-resistant cancer cells, highlighting its context-dependent dual nature.
Insights
Necroptosis, a regulated cell death pathway, plays dual roles in host defense and disease. Understanding its complex regulation offers new therapeutic targets for inflammatory and cancerous conditions.
Area of Science:
- Cellular Biology
- Immunology
- Pathology
Background:
- Necroptosis is a regulated necrotic cell death pathway crucial for host defense and disease pathogenesis.
- Its signaling networks are complex and context-dependent, necessitating a synthesized overview.
Purpose of the Study:
- To delineate necroptosis induction pathways (canonical and non-canonical).
- To elucidate the regulation of core executors (RIPK1, RIPK3, MLKL) via post-translational modifications and epigenetics.
- To analyze crosstalk between necroptosis and other cellular processes (apoptosis, autophagy, metabolism).
Main Methods:
- Review of existing literature on necroptosis signaling pathways.
- Analysis of regulatory mechanisms including post-translational modifications and epigenetic factors.
- Examination of necroptosis interplay with apoptosis, autophagy, and metabolic pathways.
Main Results:
- Detailed delineation of canonical and non-canonical necroptosis induction pathways.
- Elucidation of multifaceted regulation of RIPK1, RIPK3, and MLKL.
- Analysis of necroptosis crosstalk with apoptosis, autophagy, and metabolic pathways, revealing therapeutic vulnerabilities.
Conclusions:
- Necroptosis exhibits a context-dependent dual nature, acting in host defense and as a therapeutic strategy against cancer.
- Understanding its complex regulatory architecture presents challenges and opportunities for novel therapeutic interventions.
- Future directions involve bridging mechanistic insights to clinical applications in inflammatory, neurodegenerative, and ischemic diseases.
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Regulation of the Unfolded Protein Response
The Extrinsic Apoptotic Pathway
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
